10x Genomics and BioTuring Partner to Streamline Single Cell and Spatial Data Analysis

Reuters01-26
<a href="https://laohu8.com/S/TXG">10x Genomics</a> and BioTuring Partner to Streamline Single Cell and Spatial Data Analysis

10x Genomics Inc. has announced a strategic collaboration with BioTuring to streamline and accelerate single cell and spatial data analysis. The partnership integrates 10x Genomics’ Chromium, Xenium, and Visium platforms with BioTuring’s advanced analytical ecosystem, delivering a seamless end-to-end workflow for researchers working with complex single cell and spatial multiomics data. The collaboration aims to reduce fragmented analysis workflows and enhance the speed and depth of biological interpretation by leveraging BioTuring’s GPU-accelerated architecture and coordinated educational resources. Additionally, 10x Genomics customers new to BioTuring will receive a 30-day free access period to BioTuring’s analysis platform, with preferred pricing available thereafter. By mid-2026, the partnership is expected to enable direct data transfer from 10x Cloud Analysis into BioTuring’s platforms, further simplifying the analysis process.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief on January 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment